Newsroom

Sorted by: Latest

-

Xcel Energy 2026 First Quarter Earnings Conference Call

MINNEAPOLIS--(BUSINESS WIRE)--On Thursday, April 30, 2026, Xcel Energy (NASDAQ: XEL) will host a conference call to review first quarter 2026 financial results. The earnings report will be released prior to the market open on the same date. The call will begin at 9:00 a.m. Central Time. To participate in the conference call, please dial in at least 10 minutes prior to the scheduled start and follow the operator’s instructions. U.S. Toll-Free Dial-In: 1-800-715-9871 U.S. / International Toll Dia...
-

Samenvatting: Biocytogen en Sihuan kondigen een strategisch partnerschap in gewichtsverlies en andere domeinen aan

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), een internationaal biotechnologiebedrijf dat R&D bevordert voor nieuwe geneesmiddelen op basis van antilichamen met innovatieve technologieën, kondigde vandaag een strategisch partnerschap aan met Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). In het kader van de overeenkomst zullen beide partijen het toonaangevende platform van Biocytogen voor de...
-

Biocytogen et Sihuan Pharmaceutical annoncent un partenariat stratégique couvrant notamment la gestion de la perte de poids

PÉKIN--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE : 688796 ; HKEX : 02315), une biotech mondiale qui stimule la R&D de nouveaux médicaments à base d'anticorps grâce à des technologies innovantes, annonce aujourd'hui un partenariat stratégique avec Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical ; HKEX : 00460). En vertu de l’accord, les deux parties combineront la principale plateforme de découverte d’anticorps entièrement humains de Bi...
-

Riassunto: Biocytogen e Sihuan Pharmaceutical annunciano una partnership strategica centrata sul calo ponderale e su altri settori

PECHINO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), azienda biotecnologica globale promotrice della ricerca e dello sviluppo di nuovi farmaci a base anticorpale grazie a tecnologie innovative, oggi ha annunciato una collaborazione strategica con Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). In base ai termini dell'accordo, le due parti integreranno la piattaforma leader nella scoperta di anticorpi com...
-

Dormie Network Unveils Plans for New Clubhouse at Victoria National

LINCOLN, Neb.--(BUSINESS WIRE)--Dormie Network has announced plans to build a new clubhouse at Victoria National in Newburgh, Indiana. The project represents Dormie Network’s continued commitment to enhancing the member experience, ensuring facilities match the caliber of a golf course ranked the No. 1 Best Course in Indiana by Golf Digest. "Victoria National has come a long way since Dormie Network acquired it in 2018,” says Victoria National General Manager Brad Wilson. “As a Top 100 course i...
-

Texas Super Lawyers Honors 12 Vartabedian Katz Hester & Haynes Attorneys for 2026

DALLAS--(BUSINESS WIRE)--Twelve attorneys with litigation boutique Vartabedian Katz Hester & Haynes have been recognized among the best in the state for 2026 on the lists of both Texas Super Lawyers and Rising Stars. Honored as Texas Super Lawyers, a distinction reserved for the top 5% of attorneys, are the following firm attorneys and the areas of practice for which they were recognized: Robert Vartabedian and Rachelle “Shelley” Glazer in business litigation Marc Katz in employment & l...
-

Resumen: Biocytogen y Sihuan Pharmaceutical anuncian una alianza estratégica en el ámbito de la pérdida de peso y otros ámbitos

PEKÍN--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Pekín) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), una empresa biotecnológica internacional dedicada a la investigación y el desarrollo de nuevos fármacos basados en anticuerpos mediante tecnologías innovadoras, ha anunciado hoy una alianza estratégica con Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). En virtud del acuerdo, ambas partes combinarán la plataforma líder de Biocytogen para el descubrimiento...
-

L’AI Summit London conclut des partenariats stratégiques avec la London Business School et General Purpose pour inaugurer une nouvelle ère dans le leadership en matière d’IA

LONDRES--(BUSINESS WIRE)--L’AI Summit London, la conférence où l’IA commerciale prend vie, a annoncé des collaborations stratégiques avec la London Business School et General Purpose afin de lancer deux programmes de formation dédiés à l’IA, qui se dérouleront avant la conférence, le 9 juin. S’appuyant sur l’expertise mondialement reconnue en matière de formation des cadres de la Data Science & AI Initiative (DSAI) de la London Business School, l’AI Leadership Accelerator, d’une durée d’une...
-

Stitch Fix Resumes Share Repurchase Program

SAN FRANCISCO--(BUSINESS WIRE)--Stitch Fix, Inc. (NASDAQ: SFIX) (the “Company”), the leading online personal styling service, today announced that it has resumed repurchases under its existing share repurchase program. The share repurchase program was previously authorized by the Company’s Board of Directors in January 2022, and enables the Company to repurchase up to $150 million of its Class A common stock from time to time through open market repurchases, privately negotiated transactions, o...
-

Westwater Resources Provides Commercial Update

CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (NYSE American: WWR), an energy technology and critical minerals company focused on developing battery-grade natural graphite (“Westwater,” “Westwater Resources,” or the “Company”), today announced a commercial update. On March 31, 2026, SK On Co., Ltd. notified the Company of its decision to terminate the Products Procurement Agreement (“Agreement”) originally executed in February 2024. The Agreement represented the purchase of a po...